• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中和抗体在 SARS-CoV-2 再感染和传播中的关键作用。

Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.

机构信息

College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea.

Zoonotic Infectious Diseases Research Center, Chungbuk National University, Cheongju, Korea.

出版信息

Emerg Microbes Infect. 2021 Dec;10(1):152-160. doi: 10.1080/22221751.2021.1872352.

DOI:10.1080/22221751.2021.1872352
PMID:33407005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832474/
Abstract

Cases of laboratory-confirmed SARS-CoV-2 reinfection have been reported in a number of countries. Further, the level of natural immunity induced by SARS-CoV-2 infection is not fully clear, nor is it clear if a primary infection is protective against reinfection. To investigate the potential association between serum antibody titres and reinfection of SARS-CoV-2, ferrets with different levels of NAb titres after primary SARS-CoV-2 infection were subjected to reinfection with a heterologous SARS-CoV-2 strain. All heterologous SARS-CoV-2 reinfected ferrets showed active virus replication in the upper respiratory and gastro-intestinal tracts. However, the high NAb titre group showed attenuated viral replication and rapid viral clearance. In addition, direct-contact transmission was observed only from reinfected ferrets with low NAb titres (<20), and not from other groups. Further, lung histopathology demonstrated the presence of limited inflammatory regions in the high NAb titre groups compared with control and low NAb groups. This study demonstrates a close correlation between a low NAb titre and SARS-CoV-2 reinfection in a recovered ferret reinfection model.

摘要

已在多个国家报告了实验室确诊的 SARS-CoV-2 再感染病例。此外,SARS-CoV-2 感染诱导的自然免疫力水平尚不完全清楚,也不清楚初次感染是否对再感染具有保护作用。为了研究血清抗体滴度与 SARS-CoV-2 再感染之间的潜在关联,用不同水平的中和抗体滴度的雪貂进行了异源 SARS-CoV-2 株的再感染。所有异源 SARS-CoV-2 再感染雪貂在上呼吸道和胃肠道中均表现出活跃的病毒复制。然而,高中和抗体滴度组表现出病毒复制减弱和快速病毒清除。此外,仅从中和抗体滴度较低(<20)的再感染雪貂中观察到直接接触传播,而其他组则没有。此外,肺组织病理学显示,与对照组和低中和抗体滴度组相比,高中和抗体滴度组的炎症区域有限。这项研究在康复雪貂再感染模型中证明了低中和抗体滴度与 SARS-CoV-2 再感染之间的密切相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/8ccda3ecfd8f/TEMI_A_1872352_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/84b7d329a4b6/TEMI_A_1872352_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/b0c59f4e5a06/TEMI_A_1872352_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/563fca4e50fe/TEMI_A_1872352_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/8ccda3ecfd8f/TEMI_A_1872352_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/84b7d329a4b6/TEMI_A_1872352_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/b0c59f4e5a06/TEMI_A_1872352_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/563fca4e50fe/TEMI_A_1872352_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714b/7832474/8ccda3ecfd8f/TEMI_A_1872352_F0004_OC.jpg

相似文献

1
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.中和抗体在 SARS-CoV-2 再感染和传播中的关键作用。
Emerg Microbes Infect. 2021 Dec;10(1):152-160. doi: 10.1080/22221751.2021.1872352.
2
Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.用 SARS-CoV-2 美国-WA1/2020 参考分离株的雪貂模型中传播和防止再感染。
J Virol. 2021 Jun 10;95(13):e0223220. doi: 10.1128/JVI.02232-20.
3
The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China.江苏省 SARS-CoV-2 奥密克戎变异株再感染的血清 IgG 和中和抗体。
Front Public Health. 2024 May 30;12:1364048. doi: 10.3389/fpubh.2024.1364048. eCollection 2024.
4
Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.先前感染谱系 A 的 SARS-CoV-2 变异株可保护仓鼠免受疾病侵害,但不能预防 B.1.351 SARS-CoV-2 变异株的再感染。
Emerg Microbes Infect. 2021 Dec;10(1):1284-1292. doi: 10.1080/22221751.2021.1943539.
5
SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.SARS-CoV-2 感染可诱导叙利亚仓鼠产生保护性免疫,并限制其传播。
Life Sci Alliance. 2021 Feb 11;4(4). doi: 10.26508/lsa.202000886. Print 2021 Apr.
6
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.雪貂中 SARS-CoV-2 感染的年龄依赖性发病特征。
Nat Commun. 2022 Jan 10;13(1):21. doi: 10.1038/s41467-021-27717-3.
7
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.轻度 SARS-CoV-2 感染与再感染无关,并提供持久的刺突、核衣壳和病毒中和抗体。
Microbiol Spectr. 2021 Oct 31;9(2):e0008721. doi: 10.1128/Spectrum.00087-21. Epub 2021 Sep 1.
8
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.COVID-19 疾病的恢复情况和免疫:预测再次感染潜力的新策略。
J Adv Res. 2021 Jul;31:49-60. doi: 10.1016/j.jare.2020.12.013. Epub 2021 Jan 5.
9
Protective immunity after recovery from SARS-CoV-2 infection.新型冠状病毒感染康复后的保护性免疫。
Lancet Infect Dis. 2022 Jan;22(1):12-14. doi: 10.1016/S1473-3099(21)00676-9. Epub 2021 Nov 8.
10
Experimental re-infected cats do not transmit SARS-CoV-2.实验性再感染的猫不会传播 SARS-CoV-2。
Emerg Microbes Infect. 2021 Dec;10(1):638-650. doi: 10.1080/22221751.2021.1902753.

引用本文的文献

1
Study on SARS-CoV-2 infection in middle-aged and elderly population infected with hepatitis virus: a cohort study in a rural area of northeast China.感染肝炎病毒的中老年人群中新型冠状病毒感染的研究:中国东北地区农村地区的队列研究
PeerJ. 2025 Feb 21;13:e19021. doi: 10.7717/peerj.19021. eCollection 2025.
2
Clinical and prognostic implications of hyaluronic acid in patients with COVID-19 reinfection and first infection.透明质酸在新冠病毒二次感染和初次感染患者中的临床及预后意义
Front Microbiol. 2024 May 31;15:1406581. doi: 10.3389/fmicb.2024.1406581. eCollection 2024.
3
The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China.

本文引用的文献

1
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.新冠病毒核酸检测复阳康复患者的临床特征
Ann Transl Med. 2020 Sep;8(17):1084. doi: 10.21037/atm-20-5602.
2
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.田纳西州纳什维尔的医护人员中,针对 SARS-CoV-2 的抗体在 60 天内的变化。
JAMA. 2020 Nov 3;324(17):1781-1782. doi: 10.1001/jama.2020.18796.
3
Geographic and Genomic Distribution of SARS-CoV-2 Mutations.新型冠状病毒2变异株的地理和基因组分布
江苏省 SARS-CoV-2 奥密克戎变异株再感染的血清 IgG 和中和抗体。
Front Public Health. 2024 May 30;12:1364048. doi: 10.3389/fpubh.2024.1364048. eCollection 2024.
4
RBD-Protein/Peptide Vaccine UB-612 Elicits Mucosal and Fc-Mediated Antibody Responses against SARS-CoV-2 in Cynomolgus Macaques.RBD蛋白/肽疫苗UB-612在食蟹猴中引发针对SARS-CoV-2的黏膜和Fc介导的抗体反应。
Vaccines (Basel). 2023 Dec 29;12(1):40. doi: 10.3390/vaccines12010040.
5
SARS-CoV-2 infection in animals: Patterns, transmission routes, and drivers.动物中的新型冠状病毒2型感染:模式、传播途径及驱动因素
Eco Environ Health. 2023 Oct 13;3(1):45-54. doi: 10.1016/j.eehl.2023.09.004. eCollection 2024 Mar.
6
The panzootic potential of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的大流行潜力。
Bioscience. 2023 Dec 18;73(11):814-829. doi: 10.1093/biosci/biad102. eCollection 2023 Nov.
7
COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study.伊朗法尔斯省 COVID-19 再感染率及相关危险因素:一项回顾性队列研究。
Iran J Med Sci. 2023 May;48(3):302-312. doi: 10.30476/IJMS.2022.94615.2598.
8
Evaluation of humoral immune response in relation to COVID-19 severity over 1 year post-infection: critical cases higher humoral immune response than mild cases.评估感染 COVID-19 1 年后与严重程度相关的体液免疫反应:重症病例的体液免疫反应高于轻症病例。
Front Immunol. 2023 Jul 21;14:1203803. doi: 10.3389/fimmu.2023.1203803. eCollection 2023.
9
Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)再感染的纵向分析揭示了不同的动力学以及针对关注变异株的交叉中和抗体的出现。
Front Microbiol. 2023 Mar 29;14:1148255. doi: 10.3389/fmicb.2023.1148255. eCollection 2023.
10
SARS-CoV-2 transmission in teenagers and young adults in Fútbol Club Barcelona's Multidisciplinary Sports Training Academy.西班牙巴塞罗那足球俱乐部多学科运动训练学院青少年和年轻成年人中的 SARS-CoV-2 传播。
Eur J Pediatr. 2023 May;182(5):2421-2432. doi: 10.1007/s00431-023-04880-x. Epub 2023 Mar 14.
Front Microbiol. 2020 Jul 22;11:1800. doi: 10.3389/fmicb.2020.01800. eCollection 2020.
4
Viable SARS-CoV-2 in various specimens from COVID-19 patients.不同 COVID-19 患者样本中存活的 SARS-CoV-2。
Clin Microbiol Infect. 2020 Nov;26(11):1520-1524. doi: 10.1016/j.cmi.2020.07.020. Epub 2020 Jul 23.
5
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
6
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
7
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.SARS-CoV-2 感染可使恒河猴免受再次感染。
Science. 2020 Aug 14;369(6505):812-817. doi: 10.1126/science.abc4776. Epub 2020 May 20.
8
Herd Immunity: Understanding COVID-19.群体免疫:了解 COVID-19。
Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
9
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.雪貂、猫、狗和其他驯养动物对 SARS-CoV-2 的易感性。
Science. 2020 May 29;368(6494):1016-1020. doi: 10.1126/science.abb7015. Epub 2020 Apr 8.
10
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.